Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beijing Prediabetes Reversion Program
ChiCTR-PRC-06000005Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pioglitazone in prediabetes (4 arms), sponsored by Peking University People's Hospital. Primary endpoints: Incidence rate of diabetes and Normalization of blood glucose metabolism status. Started Jan 2007; status: completed.
02
Drugs
pioglitazone
03
Conditions
prediabetes
Beyond the preview
Go deeper on ChiCTR-PRC-06000005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-06000005.